Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 May;139(5):953-957.
doi: 10.1007/s00401-020-02144-8. Epub 2020 Mar 10.

Gliomas arising in the setting of Li-Fraumeni syndrome stratify into two molecular subgroups with divergent clinicopathologic features

Affiliations

Gliomas arising in the setting of Li-Fraumeni syndrome stratify into two molecular subgroups with divergent clinicopathologic features

Emily A Sloan et al. Acta Neuropathol. 2020 May.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflict of interest

The authors declare that they have no competing interests related to this report.

Figures

Fig. 1
Fig. 1
Clinicopathologic features of gliomas arising in the setting of Li-Fraumeni syndrome (LFS). a Imaging and histology from patient LF-1 (28-year-old woman) showing an expansile, nonenhancing, T2/FLAIR-hyperintense mass centered in the left temporal lobe with histologic features of a diffuse astrocytoma that was IDH-mutant. b Imaging and histology from patient LF-7 (4-year-old boy) showing an expansile and enhancing mass involving the thalami and left lateral ventricle with histologic features of a glioblastoma that was IDH-wildtype. c Oncoprint table of the clinicopathologic and molecular features of the 14 gliomas arising in the setting of LFS. d,e Kaplan-Meier analysis of progression-free survival (d) and disease-specific survival (e) stratified by IDH mutation status for the 14 gliomas arising in the setting of LFS. p value calculated by Log-rank (Mantel-Cox) test.

References

    1. Cancer Genome Atlas Research Network (2015) Comprehensive, integrative genomic analysis of diffuse lower-grade gliomas. N Engl J Med 372:2481–2498. - PMC - PubMed
    1. D’Angelo F, Ceccarelli M, Tala et al. (2019) The molecular landscape of glioma in patients with Neurofibromatosis 1. Nat Med 25:176–187. - PMC - PubMed
    1. Ferris SP, Goode B, Joseph NM et al. (2016) IDH1 mutation can be present in diffuse astrocytomas and giant cell glioblastomas of young children under 10 years of age. Acta Neuropathol 132:153–155. - PMC - PubMed
    1. Hayes J, Yu Y, Jalbert LE (2018) Genomic analysis of the origins and evolution of multicentric diffuse lower-grade gliomas. Neuro Oncol 20:632–641. - PMC - PubMed
    1. Kline CN, Joseph NM, Grenert JP et al. (2017) Targeted next-generation sequencing of pediatric neuro-oncology patients improves diagnosis, identifies pathogenic germline mutations, and directs targeted therapy. Neuro Oncol 19:699–709. - PMC - PubMed

Publication types

Substances